Doctor Troels Yndigegn
Department of Cardiology, Lund (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients
Event: ESC Congress 2018
Topic: Biomarkers
Session: Biomarkers in acute coronary syndromes
ESC 365 is supported by
